Mo, Yunyan, Mafei Kang, Feng Xue, Shengyuan Xu, and Jieqiong Shi. 2023. “Effectiveness and Safety of Anlotinib With or Without S-1 in the Treatment of Patients With Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study”. Radiology and Oncology 57 (3):405-10. https://radioloncol.com/index.php/ro/article/view/4122.